Search results
Ventricular Tachycardia After Cardioversion
Author(s):
Eiad Habib
,
Mahmoud Abdelnabi
,
Ramzi Ibrahim
,
et al
Added:
2 months ago
Case Report
Author(s):
Rohin K Reddy
,
James P Howard
,
Yousif Ahmad
,
et al
Added:
2 years ago
Dynamic Voltage Mapping of Ventricular Tachycardia Substrate
Author(s):
Mark T Mills
,
Peter Calvert
,
Justin Chiong
,
et al
Added:
1 year ago
Review Article
Functional Substrate Mapping
Author(s):
Jaffar Al-Sheikhli
,
Patrick Tran
,
Rafaella Siang
,
et al
Added:
1 year ago
Review Article
VT Symposium 2026
Start date:
Oct 10, 2026
End date:
Oct 09, 2026
Event
Author(s):
Pasquale Santangeli
,
Dhanunjaya Lakkireddy
Added:
3 days ago
Dr Dhanunjaya Lakkireddy (Kansas City Heart Rhythm Institute, Kansas City, US) and Dr Pasquale Santangeli (Cleveland Clinic, Cleveland, OH, US) discuss evidence-based strategies for preventing complications during complex atrial fibrillation and ventricular tachycardia ablation procedures.This expert discussion focuses on safety considerations in high-risk electrophysiology procedures, comparing…
View more
Author(s):
Pier D Lambiase
Added:
10 months ago
EHRA 2025 - We are joined onsite at EHRA Congress 2025 by Prof Pier Lambiase to discuss the latest developments in ventricular tachycardia substrate identification from the EHRA Ablation Summit 2025.Interview Questions:What are the key challenges or limitations that still exist in accurately identifying VT substrates?What are the most significant recent advancements in techniques or technologies…
View more
Added:
1 week ago
Source:
Arrhythmia Academy
A new substudy of the VANISH2 trial suggests that for patients with prior myocardial infarction and ventricular tachycardia (VT) who are eligible for sotalol, catheter ablation leads to better outcomes than antiarrhythmic drug (AAD) therapy.¹ For patients eligible only for amiodarone, efficacy was comparable, but amiodarone was associated with a significant increase in adverse events…
View more
Added:
3 weeks ago
Source:
Radcliffe Cardiology
A prespecified substudy of the VANISH2 trial suggests first-line catheter ablation is superior to sotalol for reducing arrhythmia events in eligible patients with ischaemic cardiomyopathy and ventricular tachycardia (VT).¹ In patients ineligible for sotalol, ablation showed comparable efficacy to amiodarone but with a markedly better long-term safety profile.MethodologyThe VANISH2 (Ventricular…
View more
Author(s):
Roderick Tung
Added:
2 years ago
Following the success of Rhythm Interventions Online 2022 (30 November – 2 December 2022), here Course Co-director and operator Dr Roderick Tung reviews his HD Grid Mapping in Complex VT case performed live at the event.
Includes comment and insight from fellow course leaders Prof Richard Schilling(St Bartholomew's Hospital, London, UK), Prof Julian Chun(CCB Markus Krankenhaus, Frankfurt, DE)…
View more